nach oben

Community Mental Health Journal

Erschienen in:

03.01.2020 | Original Paper

The Positive and Negative Experiences of 342 Antidepressant Users

verfasst von: John Read, Mihaela Grigoriu, Aimee Gee, Jacob Diggle, Helen Butler

Erschienen in: Community Mental Health Journal | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Most efficacy and safety studies about medications adopt a quantitative approach, testing specific hypotheses with restricted samples. This online survey provides additional insights by directly asking people open questions. Thematic analysis was used to explore the responses of 342 antidepressant users to “Is there anything else you would like to tell us about your experience of taking medication”. 59 (17.3%) made exclusively positive comments, 146 (42.7%) purely negative comments and 137 (40.0%) offered a mixture of positive and negative. Positive themes included: daily coping, life-changing/saving and stepping stone. Negative themes included: physical adverse effects, emotional and cognitive blunting, and withdrawal effects. Many participants also commented on relationships with prescribers. Collaboration was particularly valued. Negative sub-themes included failings in relation to information (especially about adverse effects and withdrawal), support, and alternatives. Clinicians have a duty to inform potential antidepressant users about positive and adverse effects, including withdrawal effects.

Adkins, D. E., Clark, S. L., Åberg, K., Hettema, J. M., Bukszár, J., McClay, J. L., et al. (2012). Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D. Translational Psychiatry,2, e129.PubMedPubMedCentralCrossRef

American Psychiatric Association. (2010). American Psychiatric association practice guideline for the treatment of patients with major depressive disorder (3rd ed.). https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidleines/guidelines/mdd.pdf.

Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology,3, 77–101.CrossRef

Byng, R., Bury, C., & Weaver, L. (2007). Patients’ experiences of consultations for depression and predictors of adherence to antidepressants. Primary Care and Community Psychiatry,12(3/4), 109–115.

Cipriani, A., Furukawa, T., Salanti, G., Chaimani, A., Atkinson, L., Ogawa, Y., et al. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet,391(10128), 1357–1366.CrossRef

Corrêa, A., Ribeiro, E., Pinto, D., & Teixeira, A. S. (2016). Therapeutic collaboration and significant events to the client’s change: A systematic review. International Journal of Psychology and Psychological Therapy,16(1), 49–60.

Davies, J., Pauli, R., & Montagu, L. (2018). All-party parliamentary group for prescribed drug dependence antidepressant withdrawal: A survey of patients’ experience by the all-party parliamentary group for prescribed drug dependence. https://prescribeddrug.org/wp-content/uploads/2018/09/APPG-PDD-A, (September).

Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors, 97, 1–10.CrossRef

Department of Health and Social Care. (2018). Hansard: Prescription drugs—Written question -128871. Department of Health and Social Care, 2018. Retrieved from https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2018-02-21/128871/

Gibson, K., Cartwright, C., & Read, J. (2014). Patient-centered perspectives on antidepressant use: A narrative review. International Journal of Mental Health,43(1), 81–99.CrossRef

Gibson, K., Cartwright, C., & Read, J. (2016). “In my life antidepressants have been..”: A qualitative analysis of users’ diverse experiences with antidepressants. BMC Psychiatry, 16(1), 1–7.CrossRef

Givens, J., Datto, C. J., Ruckdeschel, K., Knott, K., Zubritsky, C., Oslin, D., et al. (2006). Older patients’ aversion to antidepressants: A qualitative study. Journal of General Internal Medicine,21(2), 146–151.PubMedPubMedCentral

Goldsmith, L., & Moncrieff, J. (2011). The psychoactive effects of antidepressants and their association with suicidality. Current Drug Safety,6(2), 115–121.PubMedCrossRef

Guy, A., Davies, J., & Rizq, R. (Eds.). (2019). Guidance for Psychological Therapists: Enabling conversations with clients taking or withdrawing from prescribed psychiatric drugs. London: All Party Parliamentary Group for Prescribed Drug Dependence.

Jakobsen, J. C., Katakam, K. K., Schou, A., Hellmuth, S. G., Stallknecht, S. E., Leth-Møller, K., et al. (2017). Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry. https://doi.org/10.1186/s12888-016-1173-2.CrossRefPubMedPubMedCentral

Khan, A., & Brown, W. A. (2015). Antidepressants versus placebo in major depression: An overview. World Psychiatry,14(3), 294–300.PubMedPubMedCentralCrossRef

Khan, A., Khan, S., & Brown, W. A. (2002). Are placebo controls necessary to test new antidepressants and anxiolytics? International Journal of Neuropsychopharmacology,5(3), 193–197.PubMedCrossRef

Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration. PLoS Medicine,5(2), 260–268.CrossRef

Liebert, R., & Gavey, N. (2008). “I Didn't Just Cross a Line I Tripped Over an Edge”: Experiences of serious adverse effects with selective serotonin reuptake inhibitors. New Zealand Journal of Psychology,37, 38–48.

Moncrieff, J. (2015). Antidepressants: misnamed and misrepresented. World Psychiatry,14(3), 301–302.CrossRef

National Institute for Health and Care Excellence. (2009). Depression in adults: Recognition and management. Retrieved from https://www.nice.org.uk/guidance/cg90

OECD. (2017). Antidepressant drugs consumption, 2000 and 2015 (or nearest year) in Pharmaceutical sector. Paris. https://doi.org/doi.org/10.1787/health_glance-2017-graph181-en.

OECD. (2018). Prescriptions dispensed in the community—Statisitcs for England, 2001–2017.. Retrieved from https://digital.nhs.uk/data-and-information/publications/statistical/prescriptions-dispensed-in-the-community

Pestello, F., & Davis-Berman, J. (2008). Taking anti-depressant medication: A qualitative examination of internet postings. Journal of Mental Health,17(4), 349–360.CrossRef

Pratt, L. , Brody, D., & Gu, Q. (2017). Antidepressant use among persons aged 12 and over: United States, 2011–2014 key findings data from the national health and nutrition examination survey. National Center for Health Statistics, (283), 2011–2014. Retrieved from https://www.cdc.gov/nchs/data/databriefs/db283.pdf

Price, J., Cole, V., & Goodwin, G. M. (2009). Emotional side-effects of selective serotonin reuptake inhibitors: Qualitative study. British Journal of Psychiatry,195(3), 211–217.PubMedCrossRef

Read, J., Cartwright, C., & Gibson, K. (2014). Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Research,216(1), 67–73.PubMedCrossRef

Read, J., Cartwright, C., & Gibson, K. (2018). How many of 1829 antidepressant users report withdrawal effects or addiction? International Journal of Mental Health Nursing,27, 1805–1815.PubMedCrossRef

Read, J., Gee, A., Diggle, J., & Butler, H. (2017). The interpersonal adverse effects reported by 1008 users of antidepressants; and the incremental impact of polypharmacy. Psychiatry Research,256, 423–427.PubMedCrossRef

Read, J., Gee, A., Diggle, J., & Butler, H. (2019). Staying on, and coming off, antidepressants: The experiences of 752 UK adults. Addictive Behaviors,88, 82–85.PubMedCrossRef

Read, J., Gibson, K., Cartwright, C., Shiels, C., Dowrick, C., & Gabbay, M. (2015). Understanding the non-pharmacological correlates of self-reported efficacy of antidepressants. Acta Psychiatrica Scandinavica, 131, 434–445PubMedPubMedCentralCrossRef

Read, J., Gibson, K., & Cartwright, C. (2016). Do GPs and psychiatrists recommend alternatives when prescribing anti-depressants? Psychiatry Research,246(May), 838–840.PubMedCrossRef

Read, J., & Williams, J. (2018). Adverse Effects of Antidepressants Reported by 1,431 people from 38 Countries: Emotional blunting, suicidality, and withdrawal effects. Current Drug Safety,13, 1–11.CrossRef

Taylor, S., Annand, F., Burkinshaw, P., Greaves, F., Kelleher, M., Knight, J., et al. (2019). Dependence and withdrawal associated with some prescribed medicines: An evidence review. London: Public Health England.

Timimi, S., Moncrieff, J., Goetscze, P., Davies, J., Kinderman, P., Byng, R., et al. (2018). Network meta-analysis of antidepressants. (Correspondence). Lancet,392, 1011–1022.PubMedCrossRef

Titel: The Positive and Negative Experiences of 342 Antidepressant Users
verfasst von: John Read
Mihaela Grigoriu
Aimee Gee
Jacob Diggle
Helen Butler
Publikationsdatum: 03.01.2020
Verlag: Springer US
Erschienen in: Community Mental Health Journal / Ausgabe 4/2020
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-019-00535-0

Neu im Fachgebiet Psychiatrie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The Positive and Negative Experiences of 342 Antidepressant Users

Abstract

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Posttraumatic Stress Disorder, Social Support and Coping Among Afghan Refugees in Canada

The Effects of Hopelessness on Chronic Disease Among African Americans and Caribbean Blacks: Findings from the National Survey of American Life (NSAL)

Adherence to Antidepressants in Underserved Communities: A Comparison of Electronic Monitoring and Self-report Measures

State of Mental Health Among Transgender Individuals in Pakistan: Psychological Resilience and Self-esteem

Barriers to and Facilitators of Mental Health Treatment Engagement Among Latina Adolescents

Chronic Disease Screening and Prevention Activities in Mental Health Clinics in New York State: Current Practices and Future Opportunities

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie